Open Demo Account
Home / Market Update / US Allows AstraZeneca to Resume Trials of Coronavirus Vaccine

US Allows AstraZeneca to Resume Trials of Coronavirus Vaccine

Adel 26 October, 2020 11:15 am Market Update

AstraZeneca said it has resumed trials in the United States of an experimental on Covid-19 vaccine after US regulatory approval.

On September 6, AstraZeneca suspended trials of its potential experimental coronavirus vaccine in the United States after a report that a participant in Britain’s trials had contracted a serious neurological disease believed to be transverse myelitis.

Tags

Check Also

Coca-Cola Delivers Strong Earnings Boost as Investors Debate Whether the Rally Has Gone Too Far

Coca-Cola kicked off 2026 with stronger-than-expected financial results, fueled by rising consumer demand, successful marketing …

This site contains information and opinions for the purpose of providing only general information and can not be relied upon. The information and opinions contained in this Site shall in no way constitute an offer or solicitation to buy, sell or subscribe to any investment product. Users of this site shall bear any risks arising from the use of any information, opinion, program, service or material. Noor Trends reserves the right to make any change to the Site, the information, opinions, materials, products, programs, services or prices (if any) at any time without notice.
All copyrights reserved Noor Trends